In a last-minute move Wednesday, the Trump administration excluded pharmaceuticals from its retaliatory tariffs, giving ...

The recent imposition of a 27 per cent reciprocal tariff on Indian exports by the United States, while exempting the ...

These forces have set in place a wholesale rethink of the economics of the pharmaceutical industry. What has not yet emerged, however, is a clear vision of the future: most are still reacting to ...

Indian pharmaceutical exports to the U.S. were valued at approximately USD 8 billion, with the industry witnessing an 8 ...

future supply chain logistics need to be perceived as a business enabler and potential source of competitive advantage. Beyond ensuring a stable drug supply, reshoring pharmaceutical manufacturing ...